Investigation of direct neuronal and indirect, astrocyte-dependent neuromodulatory mechanisms of the pedunculopontine nucleus by Bordás, Csilla
SHORT THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PHD) 
 
Investigation of direct neuronal and indirect, astrocyte-dependent 
neuromodulatory mechanisms of the pedunculopontine nucleus 
 
by Csilla Bordás 
 
 
 
 
 
 
 
UNIVERSITY OF DEBRECEN 
DOCTORAL SCHOOL OF MOLECULAR MEDICINE  
DEBRECEN, 2017 
 
 
   
2 
 
SHORT THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PHD) 
 
Investigation of direct neuronal and indirect, astrocyte-dependent 
neuromodulatory mechanisms of the pedunculopontine nucleus 
 
by Csilla Bordás 
Supervisor: Balázs Zoltán Pál, PhD 
 
 
 
 
 
UNIVERSITY OF DEBRECEN 
DOCTORAL SCHOOL OF MOLECULAR MEDICINE  
DEBRECEN, 2017 
   
3 
 
 INVESTIGATION OF DIRECT NEURONAL AND INDIRECT, ASTROCYTE-DEPENDENT 
NEUROMODULATORY MECHANISMS OF THE PEDUNCULOPONTINE NUCLEUS 
 
 
 
By Csilla Bordás, Molecular biology MSc degree 
 
 
 
Supervisor: Balázs Zoltán Pál MD, PhD  
 
 
 
Doctoral School of Molecular Medicine, University of Debrecen 
 
 
 
Head of the Examination Committee:  János Szöllősi PhD, DSc  
Members of the Examination Committee: Klára Matesz, MD, PhD, DSc 
     Rita Gálosi MD, PhD  
 
 
The Examination takes place at 2.306 office at the Department of Biophysics and Cell 
Biology, Faculty of Medicine, University of Debrecen, at 10:30 am, 25th October, 
2017.  
 
 
Head of the Defense Committee:   János Szöllősi PhD, DSc   
Reviewers:    Attila Tóth PhD, DSc  
            Imre Kalló MD, PhD   
  
Members of the Defense Committee:  Klára Matesz MD, PhD, DSc 
Rita Gálosi MD, PhD 
 
The PhD Defense takes place at the Lecture Hall of Bldg. A, Department of Internal 
Medicine, Faculty of Medicine, University of Debrecen, at 1 pm, 25th October, 2017 
 
 
   
4 
 
INTRODUCTION 
 The pedunculopontine nucleus (PPN) is a cholinergic structure 
in the tegmentum of the midbrain.  The nucleus is located laterally from 
the superior cerebellar peduncle, and medially from the lateral 
lemniscus. It is bordered by the substantia nigra rostrally, and by the 
cuneiform and subcuneiform nucleus dorsally. This is one of the main 
cholinergic cell groups (besides the laterodorsal tegmental nucleus). 
PPN is not a homogenous structure, as it is composed of neurons with 
different neurochemical markers, and they also differ in the size of their 
soma and dendritic tree. The pedunculopontine nucleus is a part of the 
reticular activating system; its best known role is the regulation of 
sleep, wakefulness and motion.  
 The reticular activation system (RAS) is known as a structure 
which plays an important role in the organization of arousal and 
attention. The RAS is a diffuse network of nuclei that gives rise for 
ascending fibers to the cortex while receiving inputs from sensory 
structures. Several brainstem nuclei are also part of this network with 
PPN, such as laterodorsal tegmental nucleus, locus coeruleus, 
parabrachial nucleus, raphe nuclei, ventral tegmental area; and 
functionally include certain areas of the hypothalamus and the 
cholinergic basal forebrain nuclei. Inputs are generated by pain, touch, 
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heat, visual and acoustic stimuli. It reaches the cerebral cortex through 
two main pathways, which are dorsal (via the thalamus) and ventral (via 
the basal forebrain and hypothalamus).  
 Besides the PPN, there are other cholinergic structures in the 
brain. The non-motor cholinergic nuclei are located in the basal 
forebrain and in the rostral part of the brainstem, projecting to other 
brain areas. These brainstem and forebrain cholinergic structures are 
marked as Ch1-Ch6 regions. Ch1 and Ch2 belong to the medial septal 
nucleus and the nucleus of the vertical diagonal band, which form the 
most important cholinergic innervation areas of the hippocampus. 
Cholinergic nuclei of the septum form the Ch1 region. The pathway 
from the nucleus of the vertical diagonal band forms the Ch2 region, 
which is responsible for the cholinergic innervation of the 
hippocampus. The Ch3 region belongs to the lateral part of the nucleus 
of horizontal diagonal band, which is the main cholinergic input of 
bulbus olfactorius. The Ch4 pathway provides cholinergic innervation 
for the cortex and amygdala, originating from the magnocellular 
cholinergic nuclei of the nucleus basalis. Ch5 is the pedunculopontine 
nucleus, which is located in the pontomesencephalic reticular 
formation, and Ch6 is the laterodorsal tegmental nucleus (LDT) of the 
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periventricular area. These latter cholinergic pathways form the main 
cholinergic input of thalamus. 
Morphological features and connections of PPN 
 The PPN can be most easily identified with labelling of the 
cholinergic neurons. The location of cholinergic neurons is usually 
visualized with immunohistochemistry by using monoclonal antibody 
raised against the choline-acetyltransferase (ChAT) enzyme. 
Cholinergic cells in this area are 40% greater than choline-
acetyltransferase immunonegative cells. It has been recently 
demonstrated that there is a gradient in the density of cholinergic 
neurons within PPN from rostral direction to caudal direction, i.e. the 
number and proportion of cholinergic cells increase towards the caudal 
part of PPN. 
 The PPN has a well known connection with several structures, 
such as the basal forebrain, spinal cord, pontomedullar reticular 
formation, cerebellum, substantia nigra, globus pallidus and the lateral 
part of the hypothalamus. The descending pathways from the PPN are 
known to terminate on the deep cerebellar nuclei, the pontomedullar 
reticular formation, the medioventral medulla oblongata, and a weak 
cholinergic innervation of the spinal cord was also identified.  
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 The PPN and the LDT shows a significant overlap in their 
projections, but the LDT rather provides innervation for midline and 
limbic structures, whereas the PPN projects to lateral motor nuclei. 
Areas of the PPN and the LDT partially overlap with some other nuclei, 
like substantia nigra (SN) and locus coeruleus (LC). It has been shown 
that some of their projections run parallel to each other. There is 
reciprocal communication between cholinergic and cholinoceptive 
structures.  
Cell types and electrophysiological markers of the PPN 
 The PPN is not a homogeneous structure, as it consists of cells 
with different neurochemical markers. In addition to cholinergic 
neurons, numerous GABAergic and glutamatergic neurons can also be 
found, which show different density along the rostro-caudal axis of the 
nucleus. In the parasagittal axis of the nucleus, compared to cholinergic 
and glutamatergic neurons, GABAergic neurons are more densely 
located in the rostral part of the pedunculopontine nucleus. In contrast, 
glutamatergic cells are found in larger density in the caudal part of 
PPN. Further morphological subgroups can be distinguished within 
these three groups; for example, cells in PPN may differ in type and 
proportions of the calcium binding proteins expressed by them. 
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 Based on their membrane properties, different functional groups 
of PPN neurons can be also distinguished. According to Kang and 
Kitai, the following three types of neurons can be distinguished by their 
membrane properties: type I with A current (transient outward current, 
which delays repolarization to the initial membrane potential after a 
hyperpolarizing pulse), type II which has low threshold calcium spikes 
and type III, whose cell membranes do not possess these features, and 
does not fit the previous two groups. Leonard and Llinas identified 
three types of neurons based on their electrophysiological markers as 
well. The first group of PPN neurons possessed a TTX-insensitive 
calcium conductance elicited by depolarization preceded by 
hyperpolarization, which generated burst firing pattern. Neurons in the 
second group had similar low threshold calcium spikes together with A-
current. The third group includes neurons having A-currents but lacking 
low threshold calcium spikes.  
 The cholinergic and non-cholinergic neurons of PPN can also be 
grouped by their in vivo firing properties. In synchronized cortical 
activity resembling to physiological slow wave activity in anesthetized 
rats, PPN cholinergic cells showed two types of firing pattern. The 
greater population consists of slow firing cholinergic neurons, which 
showed activity in phase with the active 'up' state of the oscillations. 
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There is a small group of fast firing cholinergic neurons which were 
active during the 'down' state of the slow wave activity. Some non-
cholinergic neurons, which are mostly putative glutamatergic neurons, 
can also be divided into two groups: neurons in one group are fast firing 
and show syncronicity with the 'down' state of cortical oscillations, the 
other neuronal group consists of slow firing or quiescent neurons, with 
a firing pattern independent from the cortical slow oscillations. 
 PPN produces measurable extracellular oscillations. In PPN, the 
presence of high amplitude alpha oscillations (8-13 Hz) is 
physiologically important. The amplitude of these oscillations is 
reduced when Parkinson's disease develops. An in vitro study has 
shown that almost all PPN neurons can produce gamma-frequency 
membrane potential oscillations when they are depolarized. 
The role of PPN and its neuromodulatory regulation 
 The PPN, as a cholinergic nucleus of RAS, is involved in the 
regulation of sleep-wake cycles. It has been extensively demonstrated 
that PPN neurons increase their firing frequency during wakefulness 
and REM ("rapid eye movement") sleep, but reduce their firing 
frequency during slow wave sleep. Similar to cholinergic neurons, some 
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GABAergic and glutamatergic neurons also fire with higher frequency 
during wakefulness and REM sleep. 
 This nucleus, as one of the major cholinergic nuclei in the 
midbrain, does not only provide cholinergic input to many brain 
regions, but is itself a target for many neuromodulation mechanisms. 
 In vivo studies have shown that glutamate injection into PPN 
increased the duration of paradoxical sleep and wakefulness. Injecting 
NMDA promoted wakefulness in the experimental animal, whereas 
injection of kainate receptor agonist only increased the duration of 
paradoxical sleep. When the acetylcholine receptor agonist carbachol 
was injected to the PPN of the anesthetized animal, gamma oscillations 
appeared on the cortical EEG recording. 
 Median and dorsal raphe nuclei are connected with PPN 
together with providing serotonergic innervation to many other nuclei. 
Serotonine is able to modify the activity of PPN neurons via the 
receptor subtypes 5-HT1, 5-HT2 and 5-HT7. Serotonine receptor 
stimulation enhances wakefulness while inhibiting REM sleep, and 
inhibits the activity of PPN REM-on (cholinergic) neurons via a 
postsynaptic targets. 
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 Orexin, known to play important role in regulating food intake, 
also affects PPN cells as both subtypes of the orexin receptor are 
expressed by them. Orexin is able to inhibit both REM and non-REM 
sleep, and stabilizes wakefulness. Ghrelin can also affect the cholinergic 
neurons of PPN, by depolarizing those neurons which respond to orexin 
as well. 
The M-current 
 The M-current is a voltage-dependent, low threshold, slow-
activating, non-inactivating potassium current capable of regulating the 
excitability of neurons. It can be inhibited by the activation of a variety 
of metabotropic receptors, including muscarinic acetylcholine, 
angiotensin, substance P, purinergic, serotonine, and metabotropic 
glutamate receptors. The channel responsible for the M-current is 
formed by subunits of the KCNQ channel family (Kv7 with other 
nomenclature) which consist of subunits named KCNQ1-5 (Kv7.1-5). 
Since the activation of a number of receptors can trigger the closure of 
the M-channel, one or more common secondary messenger molecules 
mediate this process. Receptors inhibiting the M-channel are mainly G 
protein-linked receptors that activate the Gq/11 protein. Maintaining the 
responsiveness of the M-current to depolarizing stimuli, a certain PIP2 
level is required in the cell. The best known pathway is when Gq 
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activation triggers the hydrolysis of PIP2, thus inhibiting the M-current. 
As the inhibition of the M-current increases the excitability of the 
neurons, this may contribute to development of epileptic seizures. 
The endocannabinoid signaling 
 Endocannabinoids are important regulators of 
neurotransmission. According to the classic description, type 1 
cannabinoid (CB1) receptor is located on the neurons presynaptically 
and thus plays an important role in the function of the synapses. When 
endocannabinoids are bound to the receptor, Gi/o protein is activated, 
which mediates different effects through secondary messenger 
molecules. Endocannabinoids are structurally membrane lipid 
derivatives and have been named from one of the active substances of 
Cannabis sativa, the Δ9 -tetrahydrocannabinol (Δ9-THC) which is 
capable of binding to the same G protein coupled receptor.  In the brain 
and on the periphery, the arachidonoil ethanolamide (AEA, also known 
as anandamide) and the 2-arachidonoyl glycerol (2-AG) 
endocannabinoids are prototypical endocannabinoids. 
 Cannabinoids classically activate two types of receptors, such as 
cannabinoid-1 (CB1) and cannabinoid-2 (CB2) receptors. In addition to 
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classical receptors, novel receptors (such as GPR55 and GPR119) are 
also known. 
 Endocannabinoids are stored in precursor form in the plasma 
membrane so they are synthesized and then released as a result of the 
stimulation required for their release. 
 Endocannabinoids have an important functional role in the 
retrograde regulatory mechanisms of the synapses. Cannabinoid 
receptors are located in the presynaptic membrane, thus 
endocannabinoids released from the postsynaptic neuron as a result of 
postsynaptic depolarization can bind to presynaptic neuron receptors 
and inhibit neurotransmitter release. This inhibition can be short-term 
depression (STD) or long-term depression (LTD), so they contribute to 
short-term and long-term synaptic plasticity as well. Inhibition may 
occur in inhibitory (depolarization-induced suppression of inhibition: 
DSI) and excitatory (depolarization-induced suppression of excitation: 
DSE) synapses. 
 It has been recently demonstrated that, in addition to the 
neurons, astrocytes have functional CB1 receptors too. 
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Astrocyte-neuron communication 
 There is growing interest towards the role of glial cells in 
controlling neuronal functions via various mechanisms.  Glial cells have 
several different types. In the central nervous system, one can find 
macroglia, such as astrocytes, oligodendrocytes and ependymal cells; 
and microglia. Schwann cells and satellite cells can be found in the 
periphery. Within the group of astrocytes, there are further subgroups 
depending on their functional role or their location within the nervous 
system. Astrocytes play a role in forming the morphological structure of 
synapses and contribute to their proper functions. In addition, they 
mediate homeostatic effects, such as regulation of the ionic composition 
of the extracellular space and the level of neurotransmitters. In 
synapses, they form a so-called „tripartite synapse” with pre- and post-
synaptic cells with active feedback connections between them. It has 
been shown that astrocytes have several neurotransmitter receptors, 
such as ionotropic and metabotropic glutamate-, CB1, GABAB and 
other metabotropic neurotransmitter receptors. 
 Astrocytes are electrically non-excitable, they are not capable of 
producing action potentials, but are characterized by intrinsic cellular 
excitability of intracellular changes in Ca
2+
 concentration (so-called 
"calcium excitability"). The emergence of Ca
2+
 waves leads to the 
   
15 
 
release of gliotransmitters (e.g. glutamate), which may affect the 
function of the synapses around the astrocytes in different ways. 
Optogenetic activation of astrocytes 
 Optogenetics is a new, rapidly developing research technique 
that might be considered as a therapeutic option in the distant future. 
The essence of the technique is that light-gated ion channels or 
transporters found in algae or bacteria are selectively expressed by 
certain cell lines, providing possibility to influence excitability of the 
cells expressing this protein by illuminating it. The most widely used 
ion channel is channelrhodopsin-2 (ChR2), which was used in our study 
for optogenetic activation of astrocytes. This channel is originally 
expressed by the Chlamydomonas reinhardtii algae and can be activated 
by 470 nm blue light. ChR2 is a cation channel which is opened by blue 
light, permeable to Na
+
, K
+
, Ca
2+
 and H
+ 
ions. Activation of this cation 
channel depolarizes the neurons, and this leads to action potential firing. 
Activation of astrocytes is only partially due to depolarization, but 
calcium influx and intracellular acidosis (and probably by swelling of 
astrocytes) also contributes to development of its actions. 
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Neuronal currents activated by astrocytes  
 Astrocytes are able to influence neuronal excitability by 
regulating the concentration of extrasynaptic neurotransmitters. 
Extrasynaptic currents elicited by astrocytes have been observed in the 
central nervous system, which can be grouped according to magnitude, 
kinetics, direction, the type of neurotransmitters and gliotransmitters 
that trigger them, and their receptors.  
 Classifying the extrasynaptic currents based on their direction 
and duration, one can distinguish phasic outward or inward, and tonic 
excitatory or inhibitory currents.  
The phasic slow inward currents (SICs) can be easily distinguished 
from the excitatory postsynaptic currents (EPSCs), based on their 
differences in current magnitude and kinetics. They have greater 
amplitude, slower rise time and decay time. It is well established that 
activation of extrasynaptic NMDA receptors, stimulated by both 
glutamate and NMDA receptor co-activator D-serine. 
 Slow outward currents (SOC) are less common in the central 
nervous system than SICs. It is more difficult to isolate from inhibitory 
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postsynaptic currents (IPSC). SOCs have been shown to be triggered by 
the activation of GABAA receptors. 
 Tonic excitatory currents have also been shown in several brain 
structures. Their astrocytic origin is not as exclusive as in the case of 
SICs, since neurotransmitter spillover from synapses or their volume 
transmission can also elicit them. The tonic excitatory currents are 
generated by the extracellular glutamate and the NMDA receptor co-
activator glycine. The tonic inhibitory currents are generated by the 
activation of extrasynaptic GABAA receptors. In addition to GABA, 
glycine can also generate tonic inhibitory currents. 
 
OBJECTIVES/AIMS 
In our work, we investigated the mechanisms involved in PPN 
neuromodulation regulation. We sought evidence whether there are 
neuromodulatory actions only exclusively activating neurons or there 
are neuromodulatory pathways involving astrocytes as well. 
We were looking answers for the following questions: 
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1. Is there an M-type potassium current on the PPN neurons? Does 
the presence of M-current depend on cell types? 
2. What are the effects of the M-current on the electrophysiological 
characteristics of neurons? 
3. What is the role of astrocytes and metabotropic glutamate receptors 
in the tonic stimulation or inhibition of PPN neurons caused by 
CB1 receptor stimulation? 
4. Does presynaptic CB1 receptor activation exert an inhibitory effect 
on the synaptic neurotransmission of PPN? Can astrocyte-
dependent effects modify the actions of the presynaptic CB1 
receptor activation? 
 
MATERIALS AND METHODS 
Solutions 
 In the present study, artificial cerebrospinal fluid (aCSF) was 
used. For preparation of the brain, a modified cerebrospinal fluid with 
low Na concentration was used, in which the NaCl was partially 
replaced with sucrose and glycerol. 
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 For the electrophysiological experiments, an internal solution 
containing K-gluconate was used in the micropipette, the osmolarity of 
it was identical with the intracellular osmolarity. The internal solution 
also contained biocytine which was added directly into it prior to the 
experiment. 
 Calcium concentration measurement was performed using the 
acetoxymethyl ester (AM) form of Oregon Green 488 1,2-bis (o-
aminophenoxy) ethane N, N, N ', N'-tetraacetic acid (BAPTA-1) cell 
permeable fluorescent indicator. 
Animals and preparation 
 9-16 day mice were employed from both sexes. For some 
experiments, strains expressing tdTomato fluorescent protein in GAD2- 
(glutamate decarboxylase 2-) or in ChAT- (choline acetyltransferase-) 
dependent way were used.  For breeding of these mice, the cre-lox 
system was used where one parent expresses the promoter-specific 
recombinase, while the genome of the other parent contains the protein 
gene to be expressed, but its transcription is prevented by a stop codon 
bordered by two lox-P sites. For our further experiments, we used mice 
expressing channelrhodopsin-2 (ChR2) in glial fibrillary acidic protein 
–dependent way (GFAP). In some experiments, constitutional CB1 
receptor knockout mice were also employed. In some cases, 9-16 days 
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old C3H (n = 7) and C57B16 (B6) mice (n = 5) were also used from 
both sexes.  
The animals were decapitated and and 200 µm thick coronal 
midbrain slices were prepared by using a vibratome. The slices were 
incubated at 37° C in normal aCSF for 60 minutes prior to the 
recording, while continuously bubbling the chamber containing the 
slices with carbogen. 
 
Electrophysiology 
 Our experimental setup included a Zeiss Axioscope microscope 
equipped with a fluorescent imaging system composed of a xenon bulb 
based Polychrome V light source, a CCD camera, an imaging control 
unit (ICU) and a Till Vision software (Till Photonics). This system 
allows to observe changes of the fluorescence intensity in time. For 
whole-cell patch-clamp measurements, an Axopatch 200A amplifier 
was used both in voltage clamp and in current clamp mode. Data was 
recorded and processed using Clampex 10.0 software (Axon 
Instruments). 
 Recordings were performed at room temperature. The slices 
were oxygenated continuously during the recording. Patch pipettes with 
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5-6 MΩ resistance were fabricated from borosilicate glass capillaries 
using a Narishige PC-10 pipette puller. When measuring the M-current, 
the neurons were treated with 1 μM tetrodotoxin and held at -20 mV, 
followed by 1-second repolarizing steps from -60 to -30 mV. For the 
pharmacological isolation of the M-current, 20 μM XE991 was used, 
which is a specific M-current specific blocker. Current-clamp 
measurements were performed using 1 s long hyper- and depolarizing 
steps from -30 to +120 pA, and adaptation index (AI) was calculated 
from the obtained data. To measure the membrane potential 
oscillations, a 2 second long ramp protocol was used, which represents 
a linear increase in current injection with a maximum current value of 
800 pA. These measurements were performed in the presence of TTX. 
For tonic currents, spontaneous and miniature EPSCs and IPSCs 
recorded in voltage-clamp mode, the holding potential was set to -60 
mV. In some experiments, we electrically stimulated the neuronal 
presynaptic fibers innervating the investigated neuron with a monopolar 
electrode, which was placed 50-100 μm away from the subject. The 
stimulatory electrode was connected to a BioStim STC-7a stimulator 
(Supertech). Optogenetic stimulation was performed on samples from 
GFAP-ChR2 mice, for the epifluorescence stimulation of the entire 
visual field (480 ± 5 nm) a xenon bulb based Polychrome V light source 
and Till Vision software were employed. 
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 In some experiments, the CB1 receptor agonist WIN55,212-2 
was used at a concentration of 1 μM, while another CB1 receptor 
agonist ACEA was employed at 5 μM. For some experiments, 10 μM 
NBQX, 50 μM D-AP5, 1 μM strychnine and 10 μM bicuculline were 
used to inhibit fast synaptic neurotransmission. To block metabotropic 
glutamate receptors, CPCCOEt, MPEP and LY341495 were used. 
Intracellular calcium imaging 
 Prior to the measurement, slices were incubated for 45 minutes 
with 33 μM Oregon Green 488 BAPTA-1 AM (OGB) or 20 μM Rhod-2 
AM for some of our experiments. Calcium signals were taken from the 
cell’s soma filled with the calcium indicator dye. Changes of the 
fluorescence were recorded with the CCD camera and analyzed with the 
Till Vision software. 
Visualization of biocytin labeled cells 
 Cells labelled with biocytin during recordings were visualized 
with using Alexa 488 fluorescent dye conjugated streptavidin. After 
fixation with 4% paraformaldehyde, retrieval was performed in Tris 
buffered saline for 60 minutes, supplemented with Triton-X and bovine 
serum, and incubated with the Streptavidin-Alexa 488 for 90 minutes. 
Immunohistochemistry 
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 Immunohistochemical experiments were carried out in 
collaboration with the Department of Anatomy, Histology and 
Embriology. Three wild-type B6 mice were used for these experiments. 
The animals were fixed with transcardial fixation, followed by removal 
of the brain and postfixation, and then slices were prepared. Slices were 
first incubated with primary antibody solutions for 2 days at 4°C 
followed by incubation with a mixture of appropriate secondary 
antibodies. 
 
RESULTS 
Only cholinergic neurons possess M-current 
 In the first part of our experiments, one of the direct 
neuromodulatory actions of PPN neurons, the M-current was 
investigated. 
 For experiments investigating the presence of the M-current in 
the PPN, we used mouse strains expressing the fluorescence protein 
tdTomato in GAD2- or ChAT- promoter-dependent way. The M-
current is recorded by using the M-current relaxation protocol, and the 
current-specific blocking agent XE991 was used to detect the drug-
sensitive current. Using the M-current relaxation protocol, negative 
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voltage steps from -60 to -30 mV were used from -20 mV holding 
potential, in order to observe the slow closure of the M-current. The 
average amplitude of the M-current on cholinergic neurons (recorded 
during the -40 mV voltage step) was -53.9 ± 4.8 pA. The M-current can 
also be determined by administering its selective blocker, XE991, at a 
concentration of 20 μM. Determining the difference between control 
and XE991-resistant currents can reveal the M-current. Unlike 
cholinergic cells, PPN GABAergic cells did not have a current similar 
to the M-current (n = 36). 
The M-current determines the electrophysiological differences 
between cholinergic and GABAergic neurons 
 We investigated whether the presence or absence of the M-
current can cause any electrophysiological difference between 
cholinergic and GABAergic cells of the PPN. During current-clamp 
recordings, 1-second rectangular current pulses were used with 50 and 
100 pA amplitudes, while the membrane potential was set manually to -
60 mV. Significant frequency differences between the two cell types 
were observed in the action potential trains elicited by these pulses. The 
adaptation index (AI) is a measure of the decrease of action potential 
frequency within a train of action potentials. The cholinergic neurons 
displayed great adaptation while GABAergic cells had much lower AI 
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values. Medium and slow afterhyperpolarizations are considered to be 
influenced by the M-current. Afterhyperpolarization was always 
significantly greater in cholinergic cells than in GABAergic cells. In 
order to find out whether the differences between the cell types in 
question were caused by the M-current, the specific inhibitor of the M-
current, XE991 was used. This caused a decrease in the amplitude of 
firing frequency, AI and afterhiperpolarization in cholinergic neurons. 
Application of XE991 did not cause any significant change in 
GABAergic cells. The data obtained show that the presence of the M-
current plays a significant role in the differences between cholinergic 
and GABAergic neurons in firing frequency and its adaptation. 
High-threshold membrane potential oscillations are modulated by 
the M-current 
 In the next set of experiments, high-threshold membrane 
potential oscillations were investigated. Based on the literature data, 
these membrane potential changes are TTX-resistant, with P/Q and N-
type calcium channels and potassium channels are involved. A 1 second 
ramp current injection was used with a maximum current of 800 pA. 
During these experiments, we found that most cholinergic neurons had 
high threshold membrane potential oscillations, while in the case of 
GABAergic neurons none of the large amplitude oscillations were 
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observed. As a result of the XE991, the power of the oscillations greatly 
decreased. 
The synaptic and extrasynaptic effects of stimulation of CB1 
receptors on PPN neurons 
 In the second half of our experiments we have shown that, 
besides the direct neuronal effects, neuromodulation mechanisms have 
probably an astrocyte-dependent component. We have found that 
activation of astrocytes is able to induce metabotropic glutamate 
receptor (mGluR) dependent depolarization or hyperpolarization on 
PPN neurons. 
 In a previous study, our laboratory demonstrated that type 1 
cannabinoid (CB1) receptor agonists elicited heterogenous neuronal 
reactions: some neurons depolarized, others hyperpolarized, while 
others did not respond.  In the present work, we aimed to observe the 
effects of cannabinoid receptor stimulation on postsynaptic currents and 
tonic currents in order to separate the various cannabinoid effects. 
Current measurement was carried out in voltage-clamp mode at -60 
mV. Using the CB1 agonist WIN55,212-2 (1 μM) elicited tonic currents 
with amplitude ranging between + 22 and -22 pA (n = 17). In some 
cases, after application the CB1 receptor agonist, we observed slow 
inward currents (SIC) as well. In the CB1 knockout samples we found 
   
27 
 
only a minimal change in the holding current which had significant 
difference with recordings performed on wild type samples. Next, we 
attempted to isolate the direct neuronal effects of CB1 receptor 
stimulation from the indirect, astrocyte-dependent mechanisms. Slices 
were preincubated with 1 μM thapsigargin to inhibit the calcium 
excitability of astrocytes. After treatment with thapsigargin, the 
spontaneous fluctuation of the holding current was significantly 
increased compared to the untreated samples, but the CB1 receptor 
agonist did not elicit further changes of the holding current (n = 8). In 
the rest of our experiments, we observed cannabinoid effects on 
postsynaptic currents. The holding potential was set to -60 mV when 
currents were measured. Both spontaneous excitatory postsynaptic 
currents (sEPSCs) and spontaneous inhibitory postsynaptic currents 
(sIPSCs) were seen during the measurement. Adding WIN55,212-2, the 
frequency of sEPSCs was increased and the frequency of sIPSCs was 
decreased, while their amplitude did not change. Preincubation with 
thapsigargin influenced the frequency change of sEPSCs induced by 
cannabinoid agonists. Instead of frequency increase of sEPSCs, we saw 
a significant decrease of it; but the actions on sIPSCs did not differ 
from those seen without thapsigargin. It can be assumed that the 
cannabinoid effect on synaptic events is a mixture of a direct 
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presynaptic inhibitory effect via a CB1 receptor and an indirect 
astrocytic effect enhancing excitatory neurotransmission. 
Effects of optogenic activation of astrocytes on PPN neurons 
 In order to separate of the astrocyte dependent effects from 
direct neuronal CB1 receptor stimulation in a more precise way, 
optogenetics was used to selectively activate PPN astrocytes. First, we 
prepared slices from wild type and GFAP-ChR2 mice expressing the 
light-activated ion channel channelrhodopsin-2 (ChR2), which was used 
to observe the neuronal response to astrocytic stimulation. The whole 
visual field was illuminated and neurons were recorded in whole-cell 
configuration in current-clamp mode. As a result of the illumination, the 
neurons were depolarized and their firing frequencies increased. In 
voltage-clamp mode, tonic currents developed. In a few cases, 
hyperpolarization and the lack of response was also observed. Using 
mGluR inhibitors, it was also found that blocking group II mGluRs 
reduced the amplitude of the inward currents and the change in the 
holding current was significantly different from those seen under 
control conditions. As a result of the illumination, the amplitude and 
frequency of the EPSCs was also increased. Group II mGluR blockers 
almost completely prevented frequency increase (n = 12). Control 
experiments were also performed on GFAP-cre animals under the same 
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conditions as for GFAP-ChR2 animals, but the illumination did not 
exert any effect on these samples. 
Direct synaptic effects induced by CB1 receptor stimulation 
 In the next experiment, we investigated the effect of the 
presynaptic CB1 receptor activation on the excitatory postsynaptic 
currents (EPSCs). To achieve this, we used paired pulse stimulations 
with 50 Hz frequency, and stimulated the presynaptic fibers in the 
nucleus. The ratio of the second and first elicited EPSCs were 
monitored (paired pulse ratio, PPR) during the measurement. EPSCs 
were continuously detected to find out whether depolarization-induced 
suppression of excitation (DSE) exists in PPN; while the postsynaptic 
neuron was depolarized. Both postsynaptic depolarization and 
application of WIN55,212-2 caused a similar change: a decrease in 
EPSC amplitude and an increase of PPR. These cannabinoid effects 
were missing in CB1 knockout animals (n = 17). The decrease of the 
amplitude with the increase of PPR suggests the presence of presynaptic 
inhibition. When stimulation of the presynaptic fibers was performed 
together with the optogenic activation of astrocytes, no significant 
change was observed on the evoked EPSCs (n = 7). 
 After investigating the evoked EPSCs, we were looking for 
direct and indirect endocannabinoid effects on IPSCs: we investigated 
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miniature IPSCs (mIPSCs) using KCl-containing internal solutions, 
tetrodotoxin (TTX), and ionotropic glutamate receptor blockers (D -
AP5 and NBQX). The depolarization of the postsynaptic cell and the 
application of WIN similarly reduced the frequency, but did not affect 
the amplitude (n = 5).  
 Based on our experimental data described above, CB1 receptor 
activation has an indirect, astrocytic and a direct presynaptic effect. To 
confirm these results, the location of the CB1 receptor on astrocytes or 
presynaptically was detected with immunocytochemistry by our 
collaborative partners. CB1 receptor immunopositivity showed 
colocalization with GFAP, VGLUT2 and VGAT, but we almost never 
observed colocalization with ChAT. 
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DISCUSSION 
 The pedunculopontine nucleus - a brainstem nucleus regulating 
sleep and wakefulness – is under control of significant neuromodulatory 
mechanisms. These mechanisms are well described in certain cases, and 
in other cases they likely contribute to homeostatic sleep control. Based 
on the results above, it seems likely that neuromodulation mechanisms 
are only partially influenced directly by the neurons, while others 
develop via astrocytic activation. 
The M-current is a functional marker of PPN cholinergic neurons 
 In the first part of my work, I was investigating a target of 
neuromodulatory mechanisms directly affecting neurons, the so-called 
M-current. In the cholinergic cells of PPN, the presence of M-current 
was detected, while the GABAergic cells lacked this potassium current. 
 Although PPN is known as the cholinergic arm of the reticular 
activation system, GABAergic and glutamatergic neurons also form the 
nucleus. PPN neurons exhibit heterogeneity in many ways, so they can 
be grouped according to their morphological, neurochemical properties, 
electrophysiological characteristic of the cells and according to their 
role in cortical oscillations. We have shown that cholinergic cells are 
likely to be identified by the presence or absence of M-current since 
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91% of cholinergic cells were able to produce M-current. In contrast, 
GAD2-positive GABAergic neurons did not show any M-current at all. 
Our experiments on high-threshold oscillations with more than 0.3 
mV
2
/Hz power showed that this feature is also a functional marker of 
cholinergic neurons as we detected these oscillations on 82% of 
cholinergic neurons, while similar oscillations were not found on 
GABAergic cells. 
 The M-current has been recorded in many areas of the brain, 
including the brainstem. The ion channel responsible for the M-current 
is a slowly activating non-inactivating voltage-dependent potassium 
channel. The opening of the channel is controlled by several 
metabotropic receptors. Activation or inhibition of the M-current can 
change different electrophysiological properties of the neurons: due to 
the change in the input resistance and the resting membrane potential, 
the M-current can significantly control the excitability. It also 
determines the firing frequency of the neurons caused by depolarizing 
pulses and contributes to action potential firing frequency adaptation, as 
well as to the medium and slow afterhyperpolarization. In our 
experiments, we found that using identical depolarizing current step, 
GABAergic and cholinergic neurons fired at different frequencies. The 
measurements revealed that the M-current is involved in the reduction 
and adaptation of firing frequency and the amplitude of medium 
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afterhyperpolarization. Compared to the data of GABAergic cells and 
cholinergic cells in the presence of XE991, we found that there was no 
significant difference in the adaptation index at low frequency firing, 
but significant difference was revealed in the firing frequency elicited 
by higher depolarizing steps and in the amplitude of the medium 
afterhiperpolarization. This result indicates that the M-current of 
cholinergic neurons in the PPN plays an important role in firing 
frequency adaptation, but the presence or absence of M-current only 
partially contributes to the changes in firing frequency and 
afterhyperpolarization. 
 High threshold membrane potential oscillations were also 
recorded on several PPN neurons. According to certain literature data, 
this activity is in the beta-gamma frequency range while extracellularly 
measured in vivo human data supported the alpha-beta frequency range. 
Potassium-, P/Q- and N type calcium channels are responsible for this 
phenomenon. Our experiments showed that high-threshold oscillations 
are a specific feature of cholinergic neurons, which is influenced by the 
presence of the M-current. Using XE991, the M-current blocker, the 
amplitude of oscillations of cholinergic cells was significantly reduced. 
Our results and the  short-term inhibitory effect of carbachol on 
oscillations known from the literature confirm the observation that 
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muscarinic neuromodulation has multiple targets, and the M-current 
constitutes only one but significant element of these.  
Endocannabinoid effects have presynaptic and astrocyte dependent 
components as well 
 In the second part of our work, the neuronal presynaptic and 
astrocyte dependent extrasynaptic components of endocannabinoid 
effects on PPN neurons were separated. Cannabinoid signaling has 
direct presynaptic and indirect, astrocyte-dependent effects on PPN 
neurons. With the specific optogenic activation of astrocytes we 
supported the previous results of our laboratory, that astrocytic 
activation causes mGluR-dependent, tonic neuronal depolarization and 
hyperpolarization. CB1 receptor activation has a mild stimulatory effect 
on the excitatory neurotransmission and inhibits the inhibitory 
neurotransmission. The latter is probably due to the activation of 
presynaptic CB1 receptors, while the effect on excitatory 
neurotransmission is due to two factors: presynaptic inhibition on CB1 
receptors on the excitatory axon terminals and increased activity of the 
glutamatergic neurons due to increased release of glutamate from the 
astrocytes. 
 As a result of astrocytic activation, tonic neuronal inward and 
outward currents were observed. According to our laboratory's earlier 
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results, the depolarization elicited by CB1 receptor induced astrocytic 
activation can be inhibited by blocking group II mGluR receptors, while 
hyperpolarization can be inhibited by blocking group I mGluR 
receptors. It is known that astrocytes release glutamate by vesicular 
exocytosis and different channels and transporters, and are able to 
regulate extracellular glutamate levels. Glutamate released by astrocytes 
can affect the surrounding neurons, via their various mGluR, AMPA or 
NMDA receptors. It has been described in the literature that 
extrasynaptic mGluRs are capable of changing neuronal membrane 
potential and their tonic currents. We have confirmed the previous 
results from our laboratory about tonic depolarization and 
hyperpolarization, by demonstrating cannabinoid effects on tonic 
inward and outward currents. 
 The use of optogenetics allows selective activation or inhibition 
of certain cell populations. Astrocytes can be selectively activated by 
GFAP-dependent ChR2 expression and activation. Experiments with 
the optogenic activation of astrocytes have supported our theory that 
tonic changes in the excitability of PPN neurons are largely due to the 
astrocytic mechanisms. Optogenetic activation of astrocytes leads to 
stimulation of neuronal structures. The effects induced by optogenic 
activation and endocannabinoid effects are similar. Our data confirmed 
the theory that endocannabinoid effects in PPN have an indirect, 
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astrocytic component. Depolarization and neuronal tonic inward current 
are triggered by application of both CB1 receptor agonists and 
optogenetic activation of astrocytes and the effect is similarly prevented 
by blocking group II mGluR receptors. 
 In addition to support our preliminary data on astrocyte-
dependent tonic activation and inhibition on PPN cells by several 
methods, we have also shown that synaptic neurotransmission is also 
modulated by direct and indirect endocannabinoid effects in PPN. It is 
well known that CB1 receptors are predominantly presynaptically 
located in both excitatory and inhibitory synapses. There is a growing 
body of evidence that, besides the presynaptic location of the CB1 
receptors, astrocytes also have CB1 receptor in the various brain 
regions. We have also shown that both presynaptic and astrocytic CB1 
receptor can be found in the PPN. Presynaptic inhibition of inhibitory 
and excitatory neurotransmission by the CB1 receptor is a well 
established phenomenon; first described in the cerebellum and the 
hippocampus. In the present work, we first demonstrated the presence 
of DSE and DSI in PPN. The CB1 receptor agonists reduced the 
frequency of sIPSCs and mIPSCs but did not alter their amplitude. In 
contrast, the frequency of sEPSCs was increased by the CB1 receptor 
agonist WIN55,212-2. In the case of EPSCs elicited by stimulation of 
presynaptic fibers, both postsynaptic depolarization and CB1 receptor 
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agonists caused presynaptic inhibition. It is known from the literature 
that increased neuronal activity, resulting in endocannabinoid 
production, causes astrocytic glutamate release. This glutamate is able 
to facilitate glutamatergic synapses and cause long-term depression via 
NMDA receptors. We have observed that there is an astrocyte-
dependent effect increasing EPSC frequency in the PPN, that is capable 
of masking the inhibitory effect of presynaptic CB1 receptors. In 
addition, optogenic activation of astrocytes increased the frequency of 
sEPSCs via group II mGluR receptors. In contrast, optogenic activation 
of astrocytes did not affect the evoked EPSCs significantly. These 
observations have raised the possibility that increased excitability of 
glutamatergic neurons by astrocytes via group II mGluR receptors 
covers the presynaptic inhibition of CB1 receptor instead of a direct 
presynaptic, astrocyte dependent effect. The fact that inhibitory 
neurotransmission is not stimulated by indirect cannabinoid actions 
raises the possibility that there is less local GABAergic collaterals in a 
coronal slice preparation than glutamatergic collaterals. 
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SUMMARY 
The pedunculopontine nucleus (PPN) is a cholinergic member of the 
reticular activating system.  It is located in the mesopontine region, and 
its main physiological functions are the regulation of sleep-wakefulness 
cycles and movement.  Several neuromodulatory actions target the 
PPN, being parts of homeostatic and circadian sleep regulations. 
Cholinergic, serotonergic, endocannabinoid, orexin- and ghrelin-
mediated actions are known in the PPN. Although in vivo and ex vivo 
actions of these substances are documented on PPN neurons, the ways 
of action are not known in details.  The aim of our investigation was to 
separate direct neuronal and indirect, astrocyte-mediated actions of 
cholinergic and endocannabinoid mechanisms.  
We found that cholinergic neuromodulation partially influences the 
neurons via blockade of neuronal M-current.  This low-threshold-, 
slowly activating potassium current was only recorded on cholinergic 
neurons and was not found on GABAergic or non-cholinergic ones.  
The M-current was proved to be responsible for spike frequency 
adaptation and medium afterhyperpolarization.  Furthermore, it 
effectively modulated calcium current dependent high threshold 
membrane potential oscillations. 
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Direct neuronal and indirect, astrocyte-dependent components of 
endocannabinoid signaling were also investigated in the PPN.  We 
found that the metabotropic glutamate receptor dependent tonic 
excitatory or inhibitory currents elicited by CB1 receptor stimulation 
are generated via astrocyte activation.  Actions of the optogenetic 
astrocyte stimulation on neurons resembled to neuronal actions elicited 
by CB1 receptor stimulation.  Besides the astrocyte-mediated tonic 
currents, presynaptic inhibition of excitatory and inhibitory synapses 
was also demonstrated.  This action was only influenced by astrocytic 
activity via the general increase of excitability of glutamatergic 
neurons. 
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